✦ LIBER ✦

Combined treatment with cholestyramine and nicotinic acid in heterozygous familial hypercholesterolaemia: effects on biliary lipid composition

✍ Scribed by B. ANGELIN; M. ERIKSSON; K. EINARSSON

Book ID: 114726518
Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 492 KB
Volume: 16
Category: Article
ISSN: 0014-2972
DOI: 10.1111/j.1365-2362.1986.tb01014.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biliary lipid composition in heterozygou

Biliary lipid composition in heterozygous familial hypercholesterolemia and influence of treatment with probucol

✍ Naoaki Tanno; Shinichi Oikawa; Masaru Koizumi; Hidetoshi Kotake; Hidetoshi Hirak 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 663 KB

Effects of simvastatin and cholestyramin

Effects of simvastatin and cholestyramine on bile lipid composition and gallbladder motility in patients with hypercholesterolaemia

✍ J.W.A. Smit; K.J. von Erpecum; P. Portincasa; G.P. von Berge Henegouwen 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Effects of simvastatin and cholestyramin

Effects of simvastatin and cholestyramine on bile lipid composition and gallbladder motility in patients with hypercholesterolaemia

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Gemfibrozil in familial combined hyperli

Gemfibrozil in familial combined hyperlipidaemia: effect of added low-dose cholestyramine on plasma and biliary lipids

✍ B. ÖDMAN; S. ERICSSON; M. LINDMARK; L. BERGLUND; B. ANGELIN 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 523 KB

Effects of lovastatin alone and in combi

Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia

✍ Trond P. Leren; Ingvar Hjermann; Kåre Berg; Paul Leren; Olav P. Foss; Lars Viksm 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 663 KB

Short- and long-term effects of lovastat

Short- and long-term effects of lovastatin and pravastatin alone and in combination with cholestyramine on serum lipids, lipoproteins and apolipoproteins in primary hypercholesterolaemia

✍ B. G. Jacob; W. Möhrle; W. O. Richter; P. Schwandt 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 612 KB

The effects of the HMG CoA reductase inhibitors lovastatin and pravastatin on serum lipids, lipoproteins and apolipoproteins have been studied in 35 patients with primary hypercholesterolaemia. LDL cholesterol was lowered to the same extent by both agents compared on a mg basis of each drug per day.